Сlinical Trials in Georgia 2024 Georgia, a country nestled between Eastern Europe and Western Asia, has emerged as a promising destination for clinical trials. With its strategic location and favorable regulatory environment, Georgia has become increasingly attractive to international sponsors seeking to conduct innovative research projects. Since 2013, Cromos Pharma has been at the forefront of managing clinical research in Read more
Clinical Research Focus. 27th Edition Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation The escalating tensions between the US and China have permeated various sectors, including the biopharmaceutical industry, significantly impacting companies with footprints in both countries. This article explores the implications of these tensions, focusing on the case of WuXi AppTec and the Biotechnology Read more
Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation The escalating tensions between the US and China have permeated various sectors, including the biopharmaceutical industry, significantly impacting companies with footprints in both countries. This piece explores the implications of these tensions, focusing on the case of WuXi AppTec and the Biotechnology Innovation Organization’s (BIO) recent decision to sever ties. The BIO-WuXi Clash: What’s Going Read more
Exploring Clinical Trial Opportunities: Hungary’s 2024 Country Profile Hungary is recognized for its advanced regulatory framework and state-of-the-art healthcare infrastructure, attracting pharmaceutical companies and clinical research organizations (CROs) to carry out their clinical trials there. The country’s clinical trial approval process is efficient and streamlined, in line with European Union standards, which substantially shortens the time needed to initiate new trials. As a Read more